Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Lightbridge secures access to Idaho National Laboratory's Advanced Test Reactor Loop Facility for irradiation testing of its clad Lightbridge Fuel™ rodlets.
AEye secured a multi-million-dollar contract with Lunar Outpost, backed by NASA funding, to deploy Apollo™ on the Pegasus Lunar Terrain Vehicle for Artemis astronauts.
Eledon Pharmaceuticals will present Phase 2 BESTOW trial data on tegoprubart at the International Congress of The Transplantation Society on September 22, 2026.
Troilus Mining Corp. released an updated technical report for its gold-copper project in Quebec, Canada, showing an after-tax NPV5% of $3.2 billion and a 22% IRR.
Opus Genetics reported positive 3- and 6-month data from Cohort 1 of its Phase 1/2 trial for OPGx-BEST1, showing clinically meaningful improvements in visual function and retinal structure in all five participants.
Actuate Therapeutics reported preclinical data showing elraglusib's synergistic activity with RAS inhibitors zoldonrasib and daraxonrasib in pancreatic cancer models.
Can-Fite's Namodenoson treatment resolved ascites and regressed esophageal varices in a patient with decompensated cirrhosis, enabling successful bridging to liver transplantation.
SunHydrogen's 1.92 m² modules demonstrated peak active-area efficiencies approaching 9% in outdoor testing, with one full-day test averaging 7% efficiency.
